- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.03. | Blood cancers dominate CAR-T pipeline | ||
| 19.03. | USPTO allows patents for Remedy's large hemispheric infarction drug | ||
| 19.03. | Sacklers to pay up to $7bn in Purdue Pharma's opioid settlement plan | ||
| 19.03. | Insight and insitro partner on AI model to seek ocular biomarkers | ||
| 19.03. | Arbor to advance gene editing treatments with $73.9m funding | ||
| 18.03. | Opko and Entera focus on oral care for obesity and metabolic disorders | ||
| 18.03. | Curevo procures $110m and former-GSK exec for shingles vaccine candidate | ||
| 18.03. | Health Canada approves Biogen's Skyclarys for Friedreich's ataxia | ||
| 18.03. | Big tech meets biotech: Recursion and the AI gold rush in pharma | ||
| 18.03. | AstraZeneca and Alteogen agree on ALT-B4 platform tech | ||
| 17.03. | Investigating key strategies for optimising clinical trial supply chains in 2025 | ||
| 17.03. | Incyte stock hit 11% despite paediatric dermatology trials hitting target | ||
| 17.03. | Latigo secures $150m for non-opioid pain treatment development | ||
| 17.03. | Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers | ||
| 17.03. | Taiho outlays $1.14bn to acquire ADC specialist Araris | ||
| 17.03. | Azurity acquires Covis Pharma from existing investors | ||
| 17.03. | EC approves Bristol Myers Squibb's follicular lymphoma CAR T therapy | ||
| 14.03. | AstraZeneca director says AI must be a "thought partner" in drug discovery | ||
| 14.03. | Boehringer Ingelheim and Salipro enter drug discovery partnership | ||
| 14.03. | MeiraGTx and Hologen launch AI-backed gene therapy venture | ||
| 14.03. | EC approves Otsuka and Lundbeck's Rxulti for schizophrenia | ||
| 14.03. | Insilico raises $110m to develop drug pipeline and AI platform | ||
| 13.03. | Mallinckrodt and Endo sign $6.7bn merger deal | ||
| 13.03. | Vivani treats first patient with long-lasting drug implant for weight loss | ||
| 13.03. | Emergent signs financial investment agreement with Swiss Rockets |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
